²»Á¼Ñо¿Ëù

Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.

Wired spoke to ²»Á¼Ñо¿Ëù's CEO and CMO about reprogramming cells for therapies.

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.

²»Á¼Ñо¿Ëù Chief Operating Officer Kathryn Corzo featured in Endpoints News.

²»Á¼Ñо¿Ëù appoints accomplished biotechnology executive and drug developer Kathryn Corzo as Chief Operating Officer.

The pledge is part of our mission to code cells for novel cures and to be a purpose led company.

This feature covers the latest fundraise and appointments to the board.

Funding raised to accelerate and expand cell therapy pipeline.